Sadigursky David, Andion Daniel, Boureau Péricles, Ferreira Maria Cordulina, Carneiro Rogério Jamil Fernandes, Colavolpe Paulo Oliveira
. Faculdade de Tecnologia e Ciências de Salvador (FTC), Salvador, BA, Brazil.
Acta Ortop Bras. 2016 May-Jun;24(3):131-6. doi: 10.1590/1413-785220162403149200.
To analyze the effectiveness of intravenous (IV) tranexamic acid (TA) in reducing blood loss in total knee arthroplasty (TKA).
The population sample was composed of patients with a diagnosis of primary knee osteoarthritis. The patients undergoing TKA were divided in two groups. Group A: comprised patients who used IV TA and B group, formed by patients who did not use TA in the intra or post-operative period. For descriptive analysis, quantitative variables were represented by mean and standard deviations when their distribution was normal and interquartile ranges and medians for non-normal variables.
The mean age of patients was 68 years old, most of them were female and with involvement of the left knee. Postoperatively patients who had used IV TA showed less bleeding rate and less hemoglobin rate reduction.
The use of IV TA in TKA reduces blood loss in peri- and postoperative periods. Regarding total blood loss reduction, hemoglobin rate and need for blood transfusions, IV TA should be used routinely during TKA since it has been shown to be safe with no increase in side effects as thromboembolic events. Level of Evidence III. Retrospective Comparative Study.
分析静脉注射氨甲环酸(TA)在全膝关节置换术(TKA)中减少失血的有效性。
总体样本由诊断为原发性膝关节骨关节炎的患者组成。接受TKA的患者分为两组。A组:包括使用静脉TA的患者;B组:由在术中或术后未使用TA的患者组成。对于描述性分析,当定量变量分布正常时,用均值和标准差表示,对于非正态变量,用四分位间距和中位数表示。
患者的平均年龄为68岁,大多数为女性,且左膝受累。术后使用静脉TA的患者出血率较低,血红蛋白降低率也较低。
在TKA中使用静脉TA可减少围手术期和术后失血。关于减少总失血量、血红蛋白水平和输血需求,TKA期间应常规使用静脉TA,因为已证明其安全,不会增加血栓栓塞事件等副作用。证据等级III。回顾性比较研究。